Adamas Pharmaceuticals CEO Gregory Went's 2018 pay rises 20% to $3.4M
Adamas Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
Adamas Pharmaceuticals reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, four executives at Adamas Pharmaceuticals received on average a compensation package of $2.3M, a 14% decrease compared to previous year.
Average pay of disclosed executives at Adamas Pharmaceuticals
Gregory T. Went, Chief Executive Officer, received $3.4M in total, which increased by 20% compared to 2017. 60% of Went's compensation, or $2M, was in option awards. Went also received $260K in bonus, $550K in salary, $529K in stock awards, as well as $6.3K in other compensation.
Richard A. King, Chief Operating Officer, received a compensation package of $2.4M, which decreased by 22% compared to previous year. 45% of the compensation package, or $1.1M, was in option awards.
Rajiv Patni, Chief Medical Officer, earned $1.8M in 2018.
Alfred G. Merriweather, Chief Financial Officer, received $1.6M in 2018, which decreases by 21% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 25, 2019.